Global Targeted Therapy Drugs for Melanoma Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Targeted Therapy Drugs for Melanoma Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Targeted Therapy Drugs for Melanoma Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 MEK Inhibitors
  • 1.2.3 BRAF Inhibitors
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global Targeted Therapy Drugs for Melanoma Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Hospital and Clinic
  • 1.3.3 Pharmacy
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Targeted Therapy Drugs for Melanoma Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Targeted Therapy Drugs for Melanoma Revenue by Region
  • 2.2.1 Global Targeted Therapy Drugs for Melanoma Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Targeted Therapy Drugs for Melanoma Revenue by Region (2019-2024)
  • 2.2.3 Global Targeted Therapy Drugs for Melanoma Revenue by Region (2025-2030)
  • 2.2.4 Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Region (2019-2030)
• 2.3 Global Targeted Therapy Drugs for Melanoma Sales Estimates and Forecasts 2019-2030
• 2.4 Global Targeted Therapy Drugs for Melanoma Sales by Region
  • 2.4.1 Global Targeted Therapy Drugs for Melanoma Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Targeted Therapy Drugs for Melanoma Sales by Region (2019-2024)
  • 2.4.3 Global Targeted Therapy Drugs for Melanoma Sales by Region (2025-2030)
  • 2.4.4 Global Targeted Therapy Drugs for Melanoma Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Targeted Therapy Drugs for Melanoma Sales by Manufacturers
  • 3.1.1 Global Targeted Therapy Drugs for Melanoma Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Targeted Therapy Drugs for Melanoma Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Targeted Therapy Drugs for Melanoma in 2023
• 3.2 Global Targeted Therapy Drugs for Melanoma Revenue by Manufacturers
  • 3.2.1 Global Targeted Therapy Drugs for Melanoma Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Targeted Therapy Drugs for Melanoma Revenue in 2023
• 3.3 Global Key Players of Targeted Therapy Drugs for Melanoma, Industry Ranking, 2021 VS 2022
• 3.4 Global Targeted Therapy Drugs for Melanoma Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Targeted Therapy Drugs for Melanoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Targeted Therapy Drugs for Melanoma, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Targeted Therapy Drugs for Melanoma, Product Offered and Application
• 3.8 Global Key Manufacturers of Targeted Therapy Drugs for Melanoma, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Targeted Therapy Drugs for Melanoma Sales by Type
  • 4.1.1 Global Targeted Therapy Drugs for Melanoma Historical Sales by Type (2019-2024)
  • 4.1.2 Global Targeted Therapy Drugs for Melanoma Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Targeted Therapy Drugs for Melanoma Sales Market Share by Type (2019-2030)
• 4.2 Global Targeted Therapy Drugs for Melanoma Revenue by Type
  • 4.2.1 Global Targeted Therapy Drugs for Melanoma Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Targeted Therapy Drugs for Melanoma Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Type (2019-2030)
• 4.3 Global Targeted Therapy Drugs for Melanoma Price by Type
  • 4.3.1 Global Targeted Therapy Drugs for Melanoma Price by Type (2019-2024)
  • 4.3.2 Global Targeted Therapy Drugs for Melanoma Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Targeted Therapy Drugs for Melanoma Sales by Application
  • 5.1.1 Global Targeted Therapy Drugs for Melanoma Historical Sales by Application (2019-2024)
  • 5.1.2 Global Targeted Therapy Drugs for Melanoma Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Targeted Therapy Drugs for Melanoma Sales Market Share by Application (2019-2030)
• 5.2 Global Targeted Therapy Drugs for Melanoma Revenue by Application
  • 5.2.1 Global Targeted Therapy Drugs for Melanoma Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Targeted Therapy Drugs for Melanoma Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Application (2019-2030)
• 5.3 Global Targeted Therapy Drugs for Melanoma Price by Application
  • 5.3.1 Global Targeted Therapy Drugs for Melanoma Price by Application (2019-2024)
  • 5.3.2 Global Targeted Therapy Drugs for Melanoma Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Targeted Therapy Drugs for Melanoma Market Size by Type
  • 6.1.1 US & Canada Targeted Therapy Drugs for Melanoma Sales by Type (2019-2030)
  • 6.1.2 US & Canada Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2030)
• 6.2 US & Canada Targeted Therapy Drugs for Melanoma Market Size by Application
  • 6.2.1 US & Canada Targeted Therapy Drugs for Melanoma Sales by Application (2019-2030)
  • 6.2.2 US & Canada Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2030)
• 6.3 US & Canada Targeted Therapy Drugs for Melanoma Market Size by Country
  • 6.3.1 US & Canada Targeted Therapy Drugs for Melanoma Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Targeted Therapy Drugs for Melanoma Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Targeted Therapy Drugs for Melanoma Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Targeted Therapy Drugs for Melanoma Market Size by Type
  • 7.1.1 Europe Targeted Therapy Drugs for Melanoma Sales by Type (2019-2030)
  • 7.1.2 Europe Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2030)
• 7.2 Europe Targeted Therapy Drugs for Melanoma Market Size by Application
  • 7.2.1 Europe Targeted Therapy Drugs for Melanoma Sales by Application (2019-2030)
  • 7.2.2 Europe Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2030)
• 7.3 Europe Targeted Therapy Drugs for Melanoma Market Size by Country
  • 7.3.1 Europe Targeted Therapy Drugs for Melanoma Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Targeted Therapy Drugs for Melanoma Revenue by Country (2019-2030)
  • 7.3.3 Europe Targeted Therapy Drugs for Melanoma Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Targeted Therapy Drugs for Melanoma Market Size by Type
  • 8.1.1 China Targeted Therapy Drugs for Melanoma Sales by Type (2019-2030)
  • 8.1.2 China Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2030)
• 8.2 China Targeted Therapy Drugs for Melanoma Market Size by Application
  • 8.2.1 China Targeted Therapy Drugs for Melanoma Sales by Application (2019-2030)
  • 8.2.2 China Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Targeted Therapy Drugs for Melanoma Market Size by Type
  • 9.1.1 Asia Targeted Therapy Drugs for Melanoma Sales by Type (2019-2030)
  • 9.1.2 Asia Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2030)
• 9.2 Asia Targeted Therapy Drugs for Melanoma Market Size by Application
  • 9.2.1 Asia Targeted Therapy Drugs for Melanoma Sales by Application (2019-2030)
  • 9.2.2 Asia Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2030)
• 9.3 Asia Targeted Therapy Drugs for Melanoma Market Size by Region
  • 9.3.1 Asia Targeted Therapy Drugs for Melanoma Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Targeted Therapy Drugs for Melanoma Revenue by Region (2019-2030)
  • 9.3.3 Asia Targeted Therapy Drugs for Melanoma Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Roche
  • 11.1.1 Roche Company Information
  • 11.1.2 Roche Overview
  • 11.1.3 Roche Targeted Therapy Drugs for Melanoma Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Roche Targeted Therapy Drugs for Melanoma Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Roche Recent Developments
• 11.2 Pfizer
  • 11.2.1 Pfizer Company Information
  • 11.2.2 Pfizer Overview
  • 11.2.3 Pfizer Targeted Therapy Drugs for Melanoma Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Pfizer Targeted Therapy Drugs for Melanoma Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Pfizer Recent Developments
• 11.3 Novartis
  • 11.3.1 Novartis Company Information
  • 11.3.2 Novartis Overview
  • 11.3.3 Novartis Targeted Therapy Drugs for Melanoma Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Novartis Targeted Therapy Drugs for Melanoma Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Novartis Recent Developments
• 11.4 KeChow Pharmaceuticals
  • 11.4.1 KeChow Pharmaceuticals Company Information
  • 11.4.2 KeChow Pharmaceuticals Overview
  • 11.4.3 KeChow Pharmaceuticals Targeted Therapy Drugs for Melanoma Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 KeChow Pharmaceuticals Targeted Therapy Drugs for Melanoma Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 KeChow Pharmaceuticals Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Targeted Therapy Drugs for Melanoma Industry Chain Analysis
• 12.2 Targeted Therapy Drugs for Melanoma Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Targeted Therapy Drugs for Melanoma Production Mode & Process
• 12.4 Targeted Therapy Drugs for Melanoma Sales and Marketing
  • 12.4.1 Targeted Therapy Drugs for Melanoma Sales Channels
  • 12.4.2 Targeted Therapy Drugs for Melanoma Distributors
• 12.5 Targeted Therapy Drugs for Melanoma Customers

13 Targeted Therapy Drugs for Melanoma Market Dynamics

• 13.1 Targeted Therapy Drugs for Melanoma Industry Trends
• 13.2 Targeted Therapy Drugs for Melanoma Market Drivers
• 13.3 Targeted Therapy Drugs for Melanoma Market Challenges
• 13.4 Targeted Therapy Drugs for Melanoma Market Restraints

14 Key Findings in the Global Targeted Therapy Drugs for Melanoma Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Targeted Therapy Drugs for Melanoma Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of MEK Inhibitors

Table 3. Major Manufacturers of BRAF Inhibitors

Table 4. Major Manufacturers of Other

Table 5. Global Targeted Therapy Drugs for Melanoma Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Targeted Therapy Drugs for Melanoma Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Targeted Therapy Drugs for Melanoma Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Targeted Therapy Drugs for Melanoma Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Region (2019-2024)

Table 10. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Region (2025-2030)

Table 11. Global Targeted Therapy Drugs for Melanoma Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 12. Global Targeted Therapy Drugs for Melanoma Sales by Region (2019-2024) & (K Units)

Table 13. Global Targeted Therapy Drugs for Melanoma Sales by Region (2025-2030) & (K Units)

Table 14. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Region (2019-2024)

Table 15. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Region (2025-2030)

Table 16. Global Targeted Therapy Drugs for Melanoma Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global Targeted Therapy Drugs for Melanoma Sales Share by Manufacturers (2019-2024)

Table 18. Global Targeted Therapy Drugs for Melanoma Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Targeted Therapy Drugs for Melanoma, Industry Ranking, 2021 VS 2022 VS 2023

Table 21. Targeted Therapy Drugs for Melanoma Price by Manufacturers (2019-2024) & (US$/Unit)

Table 22. Global Targeted Therapy Drugs for Melanoma Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Targeted Therapy Drugs for Melanoma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy Drugs for Melanoma as of 2023)

Table 24. Global Key Manufacturers of Targeted Therapy Drugs for Melanoma, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Targeted Therapy Drugs for Melanoma, Product Offered and Application

Table 26. Global Key Manufacturers of Targeted Therapy Drugs for Melanoma, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Targeted Therapy Drugs for Melanoma Sales by Type (2019-2024) & (K Units)

Table 29. Global Targeted Therapy Drugs for Melanoma Sales by Type (2025-2030) & (K Units)

Table 30. Global Targeted Therapy Drugs for Melanoma Sales Share by Type (2019-2024)

Table 31. Global Targeted Therapy Drugs for Melanoma Sales Share by Type (2025-2030)

Table 32. Global Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Targeted Therapy Drugs for Melanoma Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Targeted Therapy Drugs for Melanoma Revenue Share by Type (2019-2024)

Table 35. Global Targeted Therapy Drugs for Melanoma Revenue Share by Type (2025-2030)

Table 36. Targeted Therapy Drugs for Melanoma Price by Type (2019-2024) & (US$/Unit)

Table 37. Global Targeted Therapy Drugs for Melanoma Price Forecast by Type (2025-2030) & (US$/Unit)

Table 38. Global Targeted Therapy Drugs for Melanoma Sales by Application (2019-2024) & (K Units)

Table 39. Global Targeted Therapy Drugs for Melanoma Sales by Application (2025-2030) & (K Units)

Table 40. Global Targeted Therapy Drugs for Melanoma Sales Share by Application (2019-2024)

Table 41. Global Targeted Therapy Drugs for Melanoma Sales Share by Application (2025-2030)

Table 42. Global Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Targeted Therapy Drugs for Melanoma Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Targeted Therapy Drugs for Melanoma Revenue Share by Application (2019-2024)

Table 45. Global Targeted Therapy Drugs for Melanoma Revenue Share by Application (2025-2030)

Table 46. Targeted Therapy Drugs for Melanoma Price by Application (2019-2024) & (US$/Unit)

Table 47. Global Targeted Therapy Drugs for Melanoma Price Forecast by Application (2025-2030) & (US$/Unit)

Table 48. US & Canada Targeted Therapy Drugs for Melanoma Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada Targeted Therapy Drugs for Melanoma Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Targeted Therapy Drugs for Melanoma Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Targeted Therapy Drugs for Melanoma Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada Targeted Therapy Drugs for Melanoma Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Targeted Therapy Drugs for Melanoma Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Targeted Therapy Drugs for Melanoma Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Targeted Therapy Drugs for Melanoma Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Targeted Therapy Drugs for Melanoma Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Targeted Therapy Drugs for Melanoma Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada Targeted Therapy Drugs for Melanoma Sales by Country (2025-2030) & (K Units)

Table 61. Europe Targeted Therapy Drugs for Melanoma Sales by Type (2019-2024) & (K Units)

Table 62. Europe Targeted Therapy Drugs for Melanoma Sales by Type (2025-2030) & (K Units)

Table 63. Europe Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Targeted Therapy Drugs for Melanoma Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Targeted Therapy Drugs for Melanoma Sales by Application (2019-2024) & (K Units)

Table 66. Europe Targeted Therapy Drugs for Melanoma Sales by Application (2025-2030) & (K Units)

Table 67. Europe Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Targeted Therapy Drugs for Melanoma Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Targeted Therapy Drugs for Melanoma Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Targeted Therapy Drugs for Melanoma Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Targeted Therapy Drugs for Melanoma Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Targeted Therapy Drugs for Melanoma Sales by Country (2019-2024) & (K Units)

Table 73. Europe Targeted Therapy Drugs for Melanoma Sales by Country (2025-2030) & (K Units)

Table 74. China Targeted Therapy Drugs for Melanoma Sales by Type (2019-2024) & (K Units)

Table 75. China Targeted Therapy Drugs for Melanoma Sales by Type (2025-2030) & (K Units)

Table 76. China Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Targeted Therapy Drugs for Melanoma Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Targeted Therapy Drugs for Melanoma Sales by Application (2019-2024) & (K Units)

Table 79. China Targeted Therapy Drugs for Melanoma Sales by Application (2025-2030) & (K Units)

Table 80. China Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Targeted Therapy Drugs for Melanoma Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Targeted Therapy Drugs for Melanoma Sales by Type (2019-2024) & (K Units)

Table 83. Asia Targeted Therapy Drugs for Melanoma Sales by Type (2025-2030) & (K Units)

Table 84. Asia Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Targeted Therapy Drugs for Melanoma Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Targeted Therapy Drugs for Melanoma Sales by Application (2019-2024) & (K Units)

Table 87. Asia Targeted Therapy Drugs for Melanoma Sales by Application (2025-2030) & (K Units)

Table 88. Asia Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Targeted Therapy Drugs for Melanoma Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Targeted Therapy Drugs for Melanoma Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Targeted Therapy Drugs for Melanoma Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Targeted Therapy Drugs for Melanoma Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Targeted Therapy Drugs for Melanoma Sales by Region (2019-2024) & (K Units)

Table 94. Asia Targeted Therapy Drugs for Melanoma Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales by Country (2025-2030) & (K Units)

Table 108. Roche Company Information

Table 109. Roche Description and Major Businesses

Table 110. Roche Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 111. Roche Targeted Therapy Drugs for Melanoma Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Roche Recent Developments

Table 113. Pfizer Company Information

Table 114. Pfizer Description and Major Businesses

Table 115. Pfizer Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 116. Pfizer Targeted Therapy Drugs for Melanoma Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Pfizer Recent Developments

Table 118. Novartis Company Information

Table 119. Novartis Description and Major Businesses

Table 120. Novartis Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 121. Novartis Targeted Therapy Drugs for Melanoma Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Novartis Recent Developments

Table 123. KeChow Pharmaceuticals Company Information

Table 124. KeChow Pharmaceuticals Description and Major Businesses

Table 125. KeChow Pharmaceuticals Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 126. KeChow Pharmaceuticals Targeted Therapy Drugs for Melanoma Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. KeChow Pharmaceuticals Recent Developments

Table 128. Key Raw Materials Lists

Table 129. Raw Materials Key Suppliers Lists

Table 130. Targeted Therapy Drugs for Melanoma Distributors List

Table 131. Targeted Therapy Drugs for Melanoma Customers List

Table 132. Targeted Therapy Drugs for Melanoma Market Trends

Table 133. Targeted Therapy Drugs for Melanoma Market Drivers

Table 134. Targeted Therapy Drugs for Melanoma Market Challenges

Table 135. Targeted Therapy Drugs for Melanoma Market Restraints

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Targeted Therapy Drugs for Melanoma Product Picture

Figure 2. Global Targeted Therapy Drugs for Melanoma Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Targeted Therapy Drugs for Melanoma Market Share by Type: 2023 & 2030

Figure 4. MEK Inhibitors Product Picture

Figure 5. BRAF Inhibitors Product Picture

Figure 6. Other Product Picture

Figure 7. Global Targeted Therapy Drugs for Melanoma Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Targeted Therapy Drugs for Melanoma Market Share by Application: 2023 & 2030

Figure 9. Hospital and Clinic

Figure 10. Pharmacy

Figure 11. Other

Figure 12. Targeted Therapy Drugs for Melanoma Report Years Considered

Figure 13. Global Targeted Therapy Drugs for Melanoma Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 15. Global Targeted Therapy Drugs for Melanoma Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 16. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 17. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Region (2019-2030)

Figure 18. Global Targeted Therapy Drugs for Melanoma Sales (2019-2030) & (K Units)

Figure 19. Global Targeted Therapy Drugs for Melanoma Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 20. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Targeted Therapy Drugs for Melanoma Sales YoY (2019-2030) & (K Units)

Figure 22. US & Canada Targeted Therapy Drugs for Melanoma Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Targeted Therapy Drugs for Melanoma Sales YoY (2019-2030) & (K Units)

Figure 24. Europe Targeted Therapy Drugs for Melanoma Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Targeted Therapy Drugs for Melanoma Sales YoY (2019-2030) & (K Units)

Figure 26. China Targeted Therapy Drugs for Melanoma Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Targeted Therapy Drugs for Melanoma Sales YoY (2019-2030) & (K Units)

Figure 28. Asia (excluding China) Targeted Therapy Drugs for Melanoma Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales YoY (2019-2030) & (K Units)

Figure 30. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Global Targeted Therapy Drugs for Melanoma Sales Share by Manufacturers (2023)

Figure 32. The Targeted Therapy Drugs for Melanoma Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 33. Global Targeted Therapy Drugs for Melanoma Revenue Share by Manufacturers (2023)

Figure 34. The Top 5 and 10 Largest Manufacturers of Targeted Therapy Drugs for Melanoma in the World: Market Share by Targeted Therapy Drugs for Melanoma Revenue in 2023

Figure 35. Global Targeted Therapy Drugs for Melanoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 36. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Type (2019-2030)

Figure 37. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Type (2019-2030)

Figure 38. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Application (2019-2030)

Figure 39. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Targeted Therapy Drugs for Melanoma Sales Market Share by Type (2019-2030)

Figure 41. US & Canada Targeted Therapy Drugs for Melanoma Revenue Market Share by Type (2019-2030)

Figure 42. US & Canada Targeted Therapy Drugs for Melanoma Sales Market Share by Application (2019-2030)

Figure 43. US & Canada Targeted Therapy Drugs for Melanoma Revenue Market Share by Application (2019-2030)

Figure 44. US & Canada Targeted Therapy Drugs for Melanoma Revenue Share by Country (2019-2030)

Figure 45. US & Canada Targeted Therapy Drugs for Melanoma Sales Share by Country (2019-2030)

Figure 46. US Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 47. Canada Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 48. Europe Targeted Therapy Drugs for Melanoma Sales Market Share by Type (2019-2030)

Figure 49. Europe Targeted Therapy Drugs for Melanoma Revenue Market Share by Type (2019-2030)

Figure 50. Europe Targeted Therapy Drugs for Melanoma Sales Market Share by Application (2019-2030)

Figure 51. Europe Targeted Therapy Drugs for Melanoma Revenue Market Share by Application (2019-2030)

Figure 52. Europe Targeted Therapy Drugs for Melanoma Revenue Share by Country (2019-2030)

Figure 53. Europe Targeted Therapy Drugs for Melanoma Sales Share by Country (2019-2030)

Figure 54. Germany Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 55. France Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 56. U.K. Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 57. Italy Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 58. Russia Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 59. China Targeted Therapy Drugs for Melanoma Sales Market Share by Type (2019-2030)

Figure 60. China Targeted Therapy Drugs for Melanoma Revenue Market Share by Type (2019-2030)

Figure 61. China Targeted Therapy Drugs for Melanoma Sales Market Share by Application (2019-2030)

Figure 62. China Targeted Therapy Drugs for Melanoma Revenue Market Share by Application (2019-2030)

Figure 63. Asia Targeted Therapy Drugs for Melanoma Sales Market Share by Type (2019-2030)

Figure 64. Asia Targeted Therapy Drugs for Melanoma Revenue Market Share by Type (2019-2030)

Figure 65. Asia Targeted Therapy Drugs for Melanoma Sales Market Share by Application (2019-2030)

Figure 66. Asia Targeted Therapy Drugs for Melanoma Revenue Market Share by Application (2019-2030)

Figure 67. Asia Targeted Therapy Drugs for Melanoma Revenue Share by Region (2019-2030)

Figure 68. Asia Targeted Therapy Drugs for Melanoma Sales Share by Region (2019-2030)

Figure 69. Japan Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 70. South Korea Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 71. China Taiwan Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 72. Southeast Asia Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 73. India Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 74. Australia Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 75. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue Market Share by Type (2019-2030)

Figure 77. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue Market Share by Application (2019-2030)

Figure 79. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Revenue Share by Country (2019-2030)

Figure 80. Middle East, Africa and Latin America Targeted Therapy Drugs for Melanoma Sales Share by Country (2019-2030)

Figure 81. Brazil Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 82. Mexico Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 83. Turkey Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 84. Israel Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 85. GCC Countries Targeted Therapy Drugs for Melanoma Revenue (2019-2030) & (US$ Million)

Figure 86. Targeted Therapy Drugs for Melanoma Value Chain

Figure 87. Targeted Therapy Drugs for Melanoma Production Process

Figure 88. Channels of Distribution (Direct Vs Distribution)

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed